The Role of the MAPH Score in Predicting Thrombus Burden in Unstable Angina Pectoris

Year 2026, Volume: 18 Issue: 1, 35 - 42, 24.03.2026

İsmail Ataş , Mümin Murat Yazıcı , Ahmet Nurhak Çakır , Oğulcan Adak , Özlem Bilir

https://doi.org/10.18521/ktd.1871763

https://izlik.org/JA57BU85BW

Abstract

Aim: Hemorheologic and viscosity-related parameters, including the Mean Platelet Volume–Age–Protein–Hematocrit (MAPH) score, have shown promising performance in predicting angiographic thrombus burden in ST segment elevation myocardial infarction (STEMI) and non-ST segment elevation myocardial infarction (NSTEMI). However, their diagnostic value in unstable angina pectoris (UAP) remains unclear. This study aimed to evaluate the predictive performance of the MAPH score compared with low-shear rate (LSR) and high-shear rate (HSR) blood viscosity parameters for estimating coronary thrombus burden in UAP.
Material and Methods: In this single-center retrospective observational study, 320 adult patients diagnosed with UAP who underwent coronary angiography were included. Thrombus burden was graded using the TIMI thrombus classification. Two cut-offs (TIMI ≥4 and ≥3) were analyzed separately. MAPH, LSR, and, HSR were calculated from admission laboratory values. Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis.
Results: High thrombus burden was observed in 10.9% (TIMI ≥4) and 17.2% (TIMI ≥3) of patients. Age, diabetes mellitus, history of coronary artery disease, and troponin levels were higher in the high-thrombus-burden groups, but MAPH, LSR, and HSR values did not differ significantly between the groups. ROC analysis demonstrated limited discrimination for all parameters. For TIMI ≥4, AUC values were 0.552 for MAPH, 0.491 for HSR, and 0.500 for LSR. For TIMI ≥3, AUCs were 0.547, 0.516, and 0.519, respectively.
Conclusion: In patients with UAP, MAPH, HSR, and LSR the ability to predict angiographic thrombus burden was limited.

Keywords

Blood viscosity , MAPH score , thrombus burden , unstable angina

Ethical Statement

The study protocol was approved by the Clinical Research Ethics Committee of Recep Tayyip Erdoğan University on January 8, 2026 (Approval No: 2026/11).

References

• 1. Rao SV, O'Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;151(13):e771–862. doi:10.1161/CIR.0000000000001309. Correction in: Circulation. 2025;151(25):e1098. doi:10.1161/CIR.0000000000001346.
• 2. Byrne RA, Rossello X, Coughlan JJC, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-826. doi:10.1093/eurheartj/ehad191.
• 3. Ataş İ, Yazıcı MM, Çakır AN, Parça N, Cerit US, Kaçan M, et al. Comparison of pretreatment in European Society of Cardiology acute coronary syndrome guidelines. West J Emerg Med. 2025;26(6):1679-87. doi:10.5811/westjem.43528.
• 4. Shi W, Liu Z, Wang Y, Bai X, Nie J, Dong T, et al. Long-term prognostic value of angiographic no-reflow phenomenon in patients with non-ST-segment elevation myocardial infarction. Catheter Cardiovasc Interv. 2026;107(1):315-25. doi:10.1002/ccd.70350.
• 5. Tsuda M, Miki Y, Ueda H, Onishi T. Distal embolization of a coronary calcified nodule during percutaneous coronary intervention without atherectomy devices. Cardiovasc Interv. 2025. doi:10.1016/j.jcin.2024.11.035.
• 6. Warny M, Helby J, Birgens HS, Bojesen SE, Nordestgaard BG. Arterial and venous thrombosis by high platelet count and high hematocrit: 108,521 individuals from the Copenhagen general population study. J Thromb Haemost. 2019;17(11):1898–911. doi:10.1111/jth.14574.
• 7. Ren H, Zheng Y, Hu X, Yang Y, Zhang Y, Sun Y, et al. High thrombus burden: a review of mechanisms and treatments. Int J Clin Exp Med. 2019;12(11):13068–78.
• 8. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47-58. doi:10.2174/138161211795049804.
• 9. Abacioglu OO, Yildirim A, Karadeniz M, Abacioglu S, Koyunsever NY, Dindas F, et al. A new score for determining thrombus burden in STEMI patients: the MAPH score. Clin Appl Thromb Hemost. 2022;28:10760296211073767. doi:10.1177/10760296211073767.
• 10. Çakmak Karaaslan Ö, Çöteli C, Özilhan MO, Akdi A, Başyiğit F, Selçuk H, et al. The predictive value of MAPH score for determining thrombus burden in patients with non-ST segment elevation myocardial infarction. Egypt Heart J. 2022;74(1):60. doi:10.1186/s43044-022-00299-1.
• 11. De Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation. 1990;81(1):107-17. doi:10.1161/01.cir.81.1.107.
• 12. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001;103(21):2550–4. doi:10.1161/01.cir.103.21.2550.
• 13. Srikanth S, Ambrose JA. Pathophysiology of coronary thrombus formation and adverse consequences of thrombus during PCI. Curr Cardiol Rev. 2012;8(3):168-76. doi:10.2174/157340312803217247.
• 14. Nakajima A, Sugiyama T, Araki M, Seegers LM, Dey D, McNulty I, et al. Plaque rupture, compared with plaque erosion, is associated with a higher level of pancoronary inflammation. JACC Cardiovasc Imaging. 2022;15(5):828-39. doi:10.1016/j.jcmg.2021.10.014.
• 15. Riascos-Bernal DF, Quinones G, Abdelaal SA, Menegus MA, Sibinga NES. Pathogenesis of plaque erosion. Trends Cardiovasc Med. 2026;36(2):105-12. doi:10.1016/j.tcm.2025.09.004.
• 16. Yamamoto E, Yonetsu T, Kakuta T, Soeda T, Saito Y, Yan BP, et al. Clinical and laboratory predictors for plaque erosion in patients with acute coronary syndromes. J Am Heart Assoc. 2019;8(21):e012322.
• 17. Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by optical coherence tomography. J Am Coll Cardiol. 2013;62:1748–58. doi:10.1016/j.jacc.2013.05.071.
• 18. Ari H. Discrepancies in the whole blood viscosity formula: which one is correct? Anatol J Cardiol. 2025;29(9):512-3. doi:10.14744/AnatolJCardiol.2025.5479.
• 19. Dzubur A, Gacic E, Mekic M. Comparison of patients with acute myocardial infarction according to age. Med Arch. 2019;73(1):23-7. doi:10.5455/medarh.2019.73.23-27.
• 20. Peng XR, Zhao YF, Zou DJ, Gu P. [The role of diabetes mellitus as a risk factor of acute myocardial infarction]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011;23(6):322-8. Chinese.
• 21. Reichlin T, Twerenbold R, Reiter M, Steuer S, Bassetti S, Balmelli C, et al. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med. 2012;125(12):1205–13. doi:10.1016/j.amjmed.2012.07.015.